- Home
- CTVA vs A Comparison
CTVA vs A Comparison
Compare CTVA & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTVA | A |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.7B | 39.8B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | CTVA | A |
|---|---|---|
| Price | $67.08 | $137.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 15 |
| Target Price | $77.81 | ★ $162.80 |
| AVG Volume (30 Days) | ★ 3.9M | 2.3M |
| Earning Date | 02-04-2026 | 11-24-2025 |
| Dividend Yield | ★ 1.07% | 0.75% |
| EPS Growth | ★ 139.00 | 3.16 |
| EPS | 2.35 | ★ 4.57 |
| Revenue | ★ $17,469,000,000.00 | $6,948,000,000.00 |
| Revenue This Year | $6.91 | $7.76 |
| Revenue Next Year | $3.51 | $6.24 |
| P/E Ratio | ★ $28.52 | $29.96 |
| Revenue Growth | 5.00 | ★ 6.73 |
| 52 Week Low | $53.40 | $96.43 |
| 52 Week High | $77.41 | $160.27 |
Technical Indicators
Market Signals| Indicator | CTVA | A |
|---|---|---|
| Relative Strength Index (RSI) | 58.90 | 36.89 |
| Support Level | $65.15 | $136.23 |
| Resistance Level | $67.46 | $143.37 |
| Average True Range (ATR) | 1.12 | 2.93 |
| MACD | 0.08 | -1.24 |
| Stochastic Oscillator | 89.58 | 7.16 |
Price Performance
Historical ComparisonAbout CTVA Corteva Inc.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in 2026 and will become a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.
About A Agilent Technologies Inc.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.